Quick Summary

Corydalis yanhusuo is a traditional Chinese medicinal herb used primarily for pain management and gynecological conditions. It contains bioactive alkaloids and has been studied for analgesic properties as well as adjunctive therapy in conditions such as endometriosis and postoperative ovarian endometriotic cysts. Clinical evidence supports its use in certain traditional Chinese medicine (TCM) formulations, but overall clinical trial quality and methodological limitations require cautious interpretation of efficacy and safety.

What is it?

Corydalis yanhusuo is a herbaceous plant commonly used in Traditional Chinese Medicine. It is recognized for its bioactive alkaloid content and is traditionally utilized for managing various types of pain and women’s health conditions. The herb is often included as part of multi-herb TCM formulations.

Traditional Uses

  • Management of different pain syndromes
  • Gynecological disorders including endometriosis and postoperative ovarian cysts
  • Inclusion in complex herbal formulas targeting women’s health and other syndromes

Active Compounds

Corydalis contains several bioactive alkaloids, which are believed to contribute to its analgesic and therapeutic properties. Network pharmacology studies have highlighted these compounds, although specific mechanisms require further clarification.

Potential Benefits with Evidence Levels

  • Pain management – Limited human clinical evidence suggests Corydalis extracts may have analgesic properties, including potential improvement in pain related to endometriotic cysts and other pain syndromes. High-quality RCTs specific to Corydalis remain limited.
  • Adjuvant treatment for postoperative ovarian endometriotic cysts – Moderate evidence from systematic reviews of 22 RCTs (n=1938) indicates that Corydalis-containing Chinese herbal medicine combined with conventional treatment may reduce cyst recurrence rates, improve clinical effective rates, and increase pregnancy rates post-surgery. Safety appears favorable but requires further verification.
  • Use in traditional Chinese medicine formulations for other indications – Preliminary clinical and mechanistic insights suggest Corydalis is commonly used in TCM formulas for various women’s health syndromes and pain management. However, clinical confirmation is generally lacking.

Side Effects

No serious adverse events specifically attributed to Corydalis yanhusuo have been reported in the clinical trials reviewed. Mild adverse effects have occasionally been noted but without significant or severe outcomes. Some cutaneous adverse reactions have been reported with traditional medicines containing Corydalis, though not conclusively linked to the herb itself.

Drug Interactions

There is limited direct evidence on drug interactions involving Corydalis yanhusuo. Given its content of bioactive alkaloids, potential interactions with other drugs—especially anticoagulants or central nervous system (CNS) active agents—cannot be excluded. Clinical caution and consultation with healthcare providers are advised when combining Corydalis with other medications.

Who Should Avoid It

No specific contraindications have been clearly established from the available human clinical studies. However, use by pregnant or breastfeeding women should be approached with caution or avoided unless under medical supervision, due to insufficient safety data in these populations.

Evidence Limitations

Most clinical studies involve Corydalis as part of multi-herb TCM formulations, which limits the ability to attribute effects solely to Corydalis. Many studies suffer from methodological weaknesses such as small sample sizes, lack of blinding, inadequate randomization, and limited long-term follow-up. High-quality randomized controlled trials and standardized outcome measures are sparse. Animal and in vitro studies exist but do not provide sufficient basis for clinical recommendations.

References

  • Ding D, Liu S, Liu F, Hao S, Zhang C, Shen Y, Wei W, Chen Q, Han F. (2024). Exploring the role of Chinese herbal medicine in the long-term management of postoperative ovarian endometriotic cysts: a systematic review and meta-analysis. Europe PMC. https://pubmed.ncbi.nlm.nih.gov/38910886/
  • Xu B, Liu Z, Zhu H, Cao J. (2016). The Antinociceptive Properties of the Corydalis yanhusuo Extract. PLoS ONE. https://doi.org/10.1371/journal.pone.0162875
  • Chen SP, Yang ST, Hu KC, Satyanarayanan SK, Su KP. (2024). Usage Patterns of Traditional Chinese Medicine for Patients with Bipolar Disorder: A Population-Based Study in Taiwan. Europe PMC. https://pubmed.ncbi.nlm.nih.gov/38391865/
  • Anonymous. (2025). A systematic review of the botany, ethnopharmacology, quality control, phytochemistry, pharmacology and pharmacokinetics of Corydalis yanhusuo. Phytochemistry Reviews. DOI: 10.1007/s11101-025-10099-5

Last Reviewed

April 2024

Informational Disclaimer: This page provides information based on current research and traditional use. It is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before starting any new herbal treatment, especially if you are pregnant, breastfeeding, have existing health conditions, or are taking other medications.